EMA’s CHMP Recommends Approval for Five New Medicines, Four New Biosimilars
By Zachary Brennan -
Published 19 May 2017
The European Medicines Agency (EMA) met earlier this week and signed off on five new medicines, including one new advanced therapy, as well as four biosimilars and one generic drug.
Categories: News, Europe, EMA, Biologics and biotechnology, Drugs, Government affairs
Tags: CHMP, Sanofi, Celltrion, XBiotech, Spherox